Health Care Products

The Food and Drug Administration oversees a broad range of medical and consumer products. In fact, the agency estimates that up to a quarter of all U.S. consumer spending is on FDA-regulated items. The Pew Charitable Trusts understands the tremendous impact these products have on public health. This project complements our work supporting drug safety and effective and efficient regulation of medical devices by focusing attention on over-the-counter drugs and dietary supplements, as well as fields such as regenerative medicine, in order to safeguard consumers and patients.

Our Work

View All
  • Pew Seeks to Streamline Over-the-Counter Drug Regulatory Process

    Every day, Americans use a variety of over-the-counter drugs, from cough and cold medicine to pain relievers and antacids. Although most consumers believe these products are safe, their regulation is antiquated and inefficient, which can put consumers at risk and hinder innovation. Read More

  • Pew Launches Health Care Products Project

    Most Americans rely on cold medicine, vitamins and other dietary supplements, and myriad other health products sold at their local convenience store. But inadequate oversight of the companies that manufacture these products can put consumers in harm’s way. The Pew Charitable Trusts is leveraging its deep expertise in public health and medical product regulation to launch an initiative that... Read More

  • Pew Supports FDA Efforts to Streamline Regulation of Over-the-Counter Drugs

    Pew has sent comments to the Food and Drug Administration supporting its proposal to establish a user fee program to that would help enable faster and more efficient review of the safety and efficacy of listed or proposed ingredients in monographs for over-the-counter drugs. In its Oct. 7 letter, Pew outlined several recommendations aimed at ensuring that FDA has adequate authority, flexibility,... Read More

Media Contact

Tami Holzman

Officer, Communications